← Browse by Condition
Medical Condition

relapsed refractory b cell mediated autoimmune diseases

Total Trials
1
Recruiting Now
1
Trial Phases
EARLY_Phase 1
NCT07322718 EARLY_Phase 1
Recruiting

Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases

Enrollment
27 pts
Location
China
Sponsor
Ruijin Hospital
View Trial →